Ignite Creation Date:
2024-05-06 @ 8:05 AM
Last Modification Date:
2024-10-26 @ 11:56 AM
Study NCT ID:
NCT02664181
Status:
COMPLETED
Last Update Posted:
2024-07-03
First Post:
2016-01-22
Brief Title:
Rational EpigenetiC Immunotherapy for SEcond Line Therapy in Patients With NSCLC PRECISE Trial
Sponsor:
Case Comprehensive Cancer Center
Organization:
Case Comprehensive Cancer Center
Organization Data
Organization:
Case Comprehensive Cancer Center
Class:
OTHER
Study ID:
CASE3516
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Case Comprehensive Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
Yogen Saunthararajah
Responsible Party Title:
Professor of Medicine
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Case Comprehensive Cancer Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |